Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial

Metabolism: Clinical and Experimental

Volumn 64, Issue 11, 2015, Pages 1582-1591

  Monti, Lucilla D ^a   Galluccio, Elena ^a   Fontana, Barbara ^a   Spadoni, Serena ^a   Comola, Mauro ^a   Marrocco Trischitta, Massimiliano M ^a   Chiesa, Roberto ^a   Comi, Giancarlo ^a   Bosi, Emanuele ^a   Piatti, Piermarco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

eNOS polymorphism; Insulin Secretion; Insulin Sensitivity; L Arginine; Pharmacogenetics

Indexed keywords

ARGININE; C PEPTIDE; N(G),N(G) DIMETHYLARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; PLACEBO;

ADULT; AGED; ALLELE; ARTICLE; CELL FUNCTION; CELL METABOLISM; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSESSMENT; DOUBLE BLIND PROCEDURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL FUNCTION; ENDOTHELIUM CELL; ENOS GENE; GENE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SENSITIVITY INDEX; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPLEMENTATION; VEIN OCCLUSION PLETHYSMOGRAPHY; CLINICAL TRIAL; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; PHARMACOGENETICS;

ARGININE; DOUBLE-BLIND METHOD; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PHARMACOGENETICS; PLACEBOS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84944441465     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.08.015     Document Type: Article

References (37)

1. L.D. Monti, E. Setola, P.C.G. Lucotti, and et al. Effect of a long-term oral L-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial Diabetes Obes Metab 14 2012 893 900
2. A. Palloshi, G. Fragasso, P. Piatti, and et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries Am J Cardiol 93 2004 933 935
3. R.H. Böger, and E.S. Ron L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor Altern Med Rev 10 2005 14 23
4. R.H. Böger Asymmetric dimethylarginine (ADMA) modulates endothelial function - therapeutic implications Vasc Med 8 2003 149 151
5. P. Vallance, and J. Leiper Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway Arterioscler Thromb Vasc Biol 24 2004 1023 1030
6. P. An, B.I. Freedman, C.L. Hanis, and et al. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis Diabetes 54 2005 909 914
7. L. Love-Gregory, R. Sherva, L. Sun, and et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol Hum Mol Genet 17 2008 1695 1704
8. J.R. Schelling, H.E. Abboud, S.B. Nicholas, and et al. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations. The family investigation of nephropathy and diabetes (FIND) Diabetes 57 2008 235 243
9. P.F. Mount, and D.A. Power Nitric oxide in the kidney: functions and regulation of synthesis Acta Physiol (Oxf) 187 2006 433 446
10. S. Moncada, and E.A. Higgs Nitric oxide and the vascular endothelium Handb Exp Pharmacol 176 2006 213 254
11. L.D. Monti, C. Barlassina, L. Citterio, and et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome Diabetes 52 2003 1270 1275
12. P.M. Piatti, E. Marone, M. Mantero, and et al. Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial Acta Diabetol 50 2013 373 382
13. E. Galluccio, L. Cassina, I. Russo, and et al. A novel truncated form of eNOS associates with altered vascular function Cardiovasc Res 101 2014 492 502
14. J. Pi, Y. Kumagai, G. Sun, and et al. Improved method for simultaneous determination of L-arginine and its mono- and dimethylated metabolites in biological samples by high-performance liquid chromatography J Chromatogr B 742 2000 199 203
15. J.M. Hill, G. Zalos, J.P. Halcox, and et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 2003 593 600
16. H. Duplain, R. Burcelin, C. Sartori, and et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase Circulation 104 2001 342 345
17. S. Nakata, M. Tsutsui, H. Shimokawa, and et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms Circulation 117 2008 2211 2223
18. E. Galluccio, P. Piatti, L. Citterio, and et al. Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis Am J Physiol Endocrinol Metab 294 2008 E978 E986
19. L. Mykkänen, S.M. Haffner, C.N. Hales, and et al. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects Diabetes 46 1997 1990 1995
20. C.C. Jensen, M. Cnop, R.L. Hull, and et al. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S Diabetes 51 2002 2170 2178
21. T. de Castro Barbosa, L.Q. Jiang, J.R. Zierath, and et al. L-Arginine enhances glucose and lipid metabolism in rat L6 myotubes via the NO/cGMP pathway Metabolism 62 1 2013 79 89
22. G. Paolisso, M.R. Tagliamonte, R. Marfella, and et al. L-Arginine but not D-Arginine stimulates insulin-mediated glucose uptake Metabolism 46 9 1997 1068 1073
23. P. Lucotti, E. Setola, L.D. Monti, and et al. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients Am J Physiol Endocrinol Metab 291 2006 E906 E912
24. L.D. Monti, M.C. Casiraghi, E. Setola, and et al. L-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome Metabolism 62 2 2013 255 264
25. R.M. Ray, M.J. Viar, and L.R. Johnson Amino acids regulate expression of antizyme-1 to modulate ornithine decarboxylase activity J Biol Chem 287 2012 3674 3690
26. J.M. Rhoads, X.M. Niu, S. Surendran, and et al. Arginine stimulates cdx2-transformed intestinal epithelial cell migration via a mechanism requiring both nitric oxide and p70s6k signaling J Nutr 138 2008 1652 1657
27. L.D. Monti, E. Galluccio, P. Lucotti, and et al. Beneficial role of L-arginine in cardiac matrix remodelling in insulin resistant rats Eur J Clin Invest 38 2008 849 856
28. J.R. McKnight, M.C. Satterfield, W.S. Jobgen, and et al. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health Amino Acids 39 2 2010 349 357
29. G. Wu, F.W. Bazer, T.A. Davis, and et al. Arginine metabolism and nutrition in growth, health and disease Amino Acids 37 1 2009 153 168
30. B. Tan, Y. Yin, Z. Liu, and et al. Dietary L-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle J Nutr Biochem 22 5 2011 441 445
31. Z. Wu, M.C. Satterfield, F.W. Bazer, and et al. Regulation of brown adipose tissue development and white fat reduction by L-arginine Curr Opin Clin Nutr Metab Care 15 6 2012 529 538
32. V. Lyssenko, P. Almgren, D. Anevski, and et al. for the Botnia Study Group. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes Diabetes 54 2005 166 174
33. A.J. Hanley, B. Zinman, P. Sheridan, and et al. Effect of rosiglitazone and ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial Diabetes Care 33 2010 608 613
34. K. Abe, M. Nakayama, M. Yoshimura, and et al. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the - 786 T > C polymorphism Pharmacogenet Genomics 15 2005 329 336
35. J.E. Tanus-Santos, M. Desai, L.R. Deak, and et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol Pharmacogenetics 12 2002 407 413
36. U. Yoon, L.L. Kwok, and A. Magkidis Efficacy of lifestyle interventions in reducing incidence in patients with impaired glucose tolerance: A systematic review of randomized controlled trials Metabolism 62 2 2013 303 314
37. L. Chen, J.-H. Pei, J. Kuang, and et al. Effect of lifestyle in patients with type 2 diabetes: A meta-analysis Metabolism 64 2 2015 338 347